Robot Schmobot …: Reply  by DeRose, Joseph J et al.
LETTERS TO THE EDITOR
Robot Schmobot . . .
Our eyes rolled as we read the recent report by DeRose et al. (1)
concerning robotically assisted left ventricular epicardial lead
implantation for biventricular pacing. This report joins a long
progression of reports of operations, cardiac and otherwise, using
the daVinci robotic surgical system. The procedure was done using
double-lumen left endobroncheal intubation, single-lung ventila-
tion, 8–10-mm Hg positive-pressure left chest insufflation, four
small incisions (each likely 1 to 2 cm), and took between 30 and
180 min of robotic operating time alone (not counting double-
lumen tube placement with bronchoscopic position confirmation,
and robot setup time).
Our hospital also has a daVinci robot system, but we have
chosen not to use it for epicardial lead placement. Rather, when
difficulty has arisen with coronary sinus lead placement in the
electrophysiology suite (four patients in the last few months), the
generator and right-sided leads are left in place, the wound is
closed, and the patient is taken to the operating room at the next
convenient opening. We use a simple single-lumen endotracheal
tube, a rolled towel under the left chest, and make a 6-cm or less
left anterior-lateral incision with minimal spreading of the ribs
using two hand-held Army-Navy retractors for left ventricular
epicardial lead placement. The procedure takes about 8 to 10 min,
including skin closure (even in the face of previous coronary bypass
grafting). The lung is not in the way; the enlarged left ventricle
rests right under the pleura in the anterior-to-mid-axillary line. No
paracostal sutures are needed for closure as the ribs are essentially
not spread. The patients have reported no more pain from this
incision than from their pacemaker site. The skin incision is small,
cosmetic, follows the natural skin lines, and rides in the subpectoral
or breast-fold crease.
The available data suggest that pacing either the mid-lateral free
wall (easily accessed through anterior-lateral thoracotomy) or the
posterobasal left ventricle gives comparable hemodynamic results
(2). We agree with the authors’ assertion that these patients are
fragile. Does the theoretical benefit of being able to reach the
posterobasal left ventricle using the robot justify the extra cost
(robot, set-up time, and disposables), extra operating time, extra
manipulation (double-lumen tube with position confirmation,
pulmonary artery catheter, transesophageal echocardiography, 4
incisions instead of 1, and a small drain site), and extra physiologic
load (right lung ventilation, collapsed left lung with positive
intrathoracic pressure)? The alternative operation is simple, inex-
pensive, quick, cosmetic, and truly minimally painful.
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REPLY
In “rolling their eyes” in response to our recent report on robotic
biventricular pacing, Drs. Lick and Saeed failed to “see” the
potential impact of an endoscopic, site-directed approach. Based
on their limited experience (four patients) of left ventricular (LV)
lead placement through a small anterior thoracotomy, they have
concluded that this approach is superior to robotic, endoscopic lead
placement. Unfortunately, follow-up echocardiographic and clin-
ical data are unavailable on these patients, and supporting data for
this approach are lacking in the contemporary international liter-
ature.
We have performed over 100 limited anterior and antero-lateral
thoracotomies for both minimally invasive mitral valve repair and
robotically assisted minimally invasive coronary artery bypass graft
(CABG). These incisions have propelled forward the field of
minimally invasive cardiac surgery, and we continue to work
toward totally endoscopic treatments for complex cardiac disease.
However, it was our vast experience with these incisions that made
us conclude that this was exactly the wrong approach for the
intricacies of biventricular pacing. In our experience with both
single- and multi-vessel robotically assisted minimally invasive
CABG through a limited (6 cm) antero-lateral thoracotomy, we
have found that even with endoscopic stabilization in normal-sized
hearts, the most lateral access to the LV is the region of a ramus
intermedius or high obtuse marginal vessel. In the massively
enlarged hearts that we have encountered in our robotic biven-
tricular pacing experience (mean left ventricular end-diastolic
diameter, 6.9 cm), the obtuse marginal (OM) vessels are displaced
even further laterally into the left chest. In these cases, limited
anterior thoracotomy results in a “keyhole” view of, at best, the
region of the first diagonal and mostly the region of the left
anterior descending coronary artery (LAD). If Drs. Lick and Saeed
were able to access the true lateral wall (region between OM1 and
OM2) with this incision, then they have accomplished something
in four cases that minimally invasive CABG surgeons have been
trying to do in normal hearts for the past five years. Limited lateral
and postero-lateral thoracotomy with the patient in the full
decubitus position has been described for OM access, but this is
not the procedure that the authors are referring to.
As electrophysiologists have known for years, LV stimulation
site is critical to the success of cardiac resynchronization therapy
(CRT). In both short- and long-term studies, it is clear that
coronary sinus leads in the postero-lateral distribution provide
better hemodynamic results than lateral sites, which provide still
better augmentation than anterior sites (1,2). The obvious advan-
tage to the robotic, totally endoscopic approach is the ability to
access the entire LV. This access allows both electrophysiologic
and echocardiographic mapping of the LV in order to delineate the
best LV site for CRT. It is our hope that we will be able to improve
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upon the 33% “non-responder” rate to CRT with such an
approach.
Finally, Drs. Lick and Saeed imply that robotic CRT with
single-lung ventilation and chest insufflation is a physiologically
taxing procedure for these frail patients. In most cases we perform
lead placement without chest insufflation. However, a pilot study
at our institution analyzing the hemodynamic and subtle echocar-
diographic effects of chest insufflation in patients undergoing
robotic cardiac surgery revealed no hemodynamic consequences in
the biventricular pacing population. In fact, it was these very
patients with high intracardiac pressures and large cardiac/
pulmonary ratios who were most resistant to insufflation (Belsley et
al., unpublished data, June 2003).
As with any new technology, robotic surgery does require the
seamless coordination of the surgical, nursing, and anesthesia
teams. At our institution, we have performed 65 robotic cases over
an 18-month period, and this seamless process occurs without
delays in our operating room. The skin-to-skin robotic times for
our last 15 cases averaged 45 min, and these times are accurately
recorded as part of a number of ongoing trials. Drs. Lick and Saeed
report an operative time of “8 to 10 minutes” for their procedure.
It is unclear whether this “time” actually includes incision, lead
placement, lead tesing, tunneling, device connection, and skin
closure.
The optimal CRT implantation procedure may not yet have
been identified, but it is hoped that continued scientific investiga-
tion will improve the way we treat patients with refractory heart
failure. We must continue to keep our “eyes” focused on the past
while maintaining a vision for the future.
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